Decreased Susceptibility ofStreptococcus pneumoniaeto Fluoroquinolones in Canada

Abstract
Fluoroquinolones are now recommended for the treatment of respiratory tract infections due to Streptococcus pneumoniae, particularly when the isolates are resistant to β-lactam antibiotics. Although pneumococci with reduced susceptibility to fluoroquinolones have been identified, their prevalence has not been determined in a defined population.

This publication has 39 references indexed in Scilit: